MyronMaxLevineMD
Infectious Disease • Baltimore, MDProfessor, Medicine, University of Maryland School of Medicine
Dr. Levine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22 S Greene St
Baltimore, MD 21201Phone+1 410-328-5793Fax+1 410-328-0248
Education & Training
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 1967 - 1970
Virginia Commonwealth University School of MedicineClass of 1967
Certifications & Licensure
MD State Medical License 1971 - 2024- American Board of Pediatrics Pediatrics
- American Board of Preventive Medicine General Preventive Medicine
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 1995
- Elected Member The American Society for Clinical Investigation, 1986
Clinical Trials
- Maternal Flu Vaccine Trial in Bamako, Mali Start of enrollment: 2011 Sep 12
Publications & Presentations
PubMed
- Clinical Severity of Enteric Viruses Detected Using a Quantitative Molecular Assay Compared With Conventional Assays in the Global Enteric Multicenter Study.Jordan Cates, Helen Powell, James Platts-Mills, Dilruba Nasrin, Sandra Panchalingam
The Journal of Infectious Diseases. 2024-11-15 - 2 citationsPredicting Vibrio cholerae infection and symptomatic disease: a systems serology study.Kirsten E Wiens, Anita S Iyer, Taufiqur R Bhuiyan, Lenette L Lu, Deniz Cizmeci
The Lancet. Microbe. 2023-04-01 - 2 citationsImpact of rotavirus vaccination on diarrheal hospitalizations in children younger than 5 years of age in a rural southern Mozambique.Filomena Manjate, Llorenç Quintó, Percina Chirinda, Sozinho Acácio, Marcelino Garrine
Vaccine. 2022-10-19
Press Mentions
Three University of Maryland School of Medicine Faculty Members Honored by Baltimore Business JournalNovember 1st, 2022- New Study Confirms Typhoid Vaccine Safety, Immune Response in ChildrenAugust 9th, 2022
- Two University of Maryland School of Medicine Women Faculty Leaders Featured in New BookMarch 16th, 2022
- Join now to see all
Grant Support
- Vaccine Strategy For Broad Spectrum Protection Agains Non-Typhoidal SalmonellNational Institute Of Allergy And Infectious Diseases2009–2012
- University Of Maryland Development Research ProgramNational Institute Of Allergy And Infectious Diseases2009–2012
- Middle Atlantic Regional Center For Excellence For Biodefense And Emerging InfectNational Institute Of Allergy And Infectious Diseases2009–2012
- Administrative CoreNational Institute Of Allergy And Infectious Diseases2008–2012
- Phase I Trial Of Two Candidate Live Oral Salmonella Enterica Serovar Paratyphi ANational Institute Of Allergy And Infectious Diseases2009–2011
- Fellowship Training Program In VaccinologyNational Institute Of Allergy And Infectious Diseases1997–2011
- New Opportunities - Heterologous Prime-Boost Product Development ProjectNational Institute Of Allergy And Infectious Diseases2008
- Defense Against Biowarfare And Emerging Infection AgentsNational Institute Of Allergy And Infectious Diseases2003–2008
- Recombinant &Live Oral Salmonella Typhi Hybrid VaccinesNational Institute Of Allergy And Infectious Diseases1990–2008
- Bacterial Live Vector-Based Vaccine Against MalariaNational Institute Of Allergy And Infectious Diseases2000–2004
- International Training And Research In Emerging InfectioFogarty International Center1997–2002
- Training &Research In MaliFogarty International Center2000
- Noma In Children In Deprived CommunitiesFogarty International Center1998–2000
- Control Mesures In Aging And Infectious DiseaseNational Institute Of Allergy And Infectious Diseases1994–2000
- Training And Research In MaliFogarty International Center1999
- Multivalent Salmonella Typhi Based Malaria VaccinesNational Institute Of Allergy And Infectious Diseases1997–1999
- Oral Immunization Against Enteric Infections In ChileNational Institute Of Allergy And Infectious Diseases1994–1998
- Recombinant &Live Oral Salmonella Typhi Hybrid VaccinesNational Institute Of Allergy And Infectious Diseases1997
- Recombinant And Live Oral Salmonella Typhi VaccinesNational Institute Of Allergy And Infectious Diseases1993–1996
- Control Measures In Aging And Infectious DiseaseNational Institute Of Allergy And Infectious Diseases1995
- Malaria Vaccine Research And Development ProjectNational Institute Of Allergy And Infectious Diseases1994–1995
- Control Measures Against Infect Disease Other THAN AIDSNational Institute Of Allergy And Infectious Diseases1994
- Enteric Diseases Vaccine Evaluation &Treatment UnitNational Institute Of Allergy And Infectious Diseases1991–1994
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
